Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-26.27M
↓ 79% vs avg
Percentile
P0
Near historical low
Streak
9 yr
Consecutive declineContracting
Average
$-14.71M
Historical baseline
PeriodValueYoY Change
TTM$-26.27M-24.9%
2024$-21.03M-0.4%
2023$-20.94M-0.9%
2022$-20.76M-26.0%
2021$-16.47M-42.4%
2020$-11.57M-26.7%
2019$-9.13M-1.9%
2018$-8.96M-35.9%
2017$-6.59M-22.7%
2016$-5.37M-